Robert D Stephens

US Patent:

6449260, Sep 10, 2002

Filed:

May 1, 1998

Appl. No.:

09/071759

Inventors:

Michael Sassin - San Jose CA
Markku Korpi - Starnberg, DE
Richard W. Crouch - Gustine CA
Leon Xu - San Jose CA
Uwe Wrede - San Jose CA
Robert W. Stephens - Sunnyvale CA

Assignee:

Siemens Information and Communication Networks, Inc. - Boca Raton FL

International Classification:

H04Q 902

US Classification:

370270, 370352, 370389, 370401, 379265

Abstract:

An automatic call distribution system utilizes a number of H. 323 compatible devices. An automatic call distribution (ACD) server ( ) interfaces with a computer telephony interface gateway ( ) to route calls to agents or to a music/video server ( ). Calls are received by a gateway and supplied to a gatekeeper that determines an IP address of the destination. The ACD server selects the destination in response to the number of agents available. In addition, customer calls can be received via e-mail, facsimile or the Internet. The call distribution system can instruct an agent to return an e-mail or facsimile message or to call a customer if desired. Calls from one H. 323 device can be routed to another H. 323 device by a third party application by sending a call control message to the devices application program interface that executes the message as if it were generated at the device itself.

US Patent:

6561195, May 13, 2003

Filed:

Mar 26, 2001

Appl. No.:

09/817806

Inventors:

W. Robert Addington - Melbourne Beach FL
Robert E. Stephens - Kansas City MO
Stuart P. Miller - Melbourne Beach FL

Assignee:

Pneumoflex Systems L.L.C. - Melbourne FL

International Classification:

A61B 508

US Classification:

128898, 600529

Abstract:

A laryngoscope-associated arrangement provides for focused delivery of a chemostimulant from a nebulizer through a delivery conduit to a patients larynx to allow a practitioner to directly observe the function of the patients larynx during the course of delivery of the chemostimulant. This not only provides the practitioner with a visualization of whether the patients laryngeal vestibule is functioning properly, but allows the practitioner to be satisfied that the chemostimulant is accurately delivered to the intended region of interest.

US Patent:

6568397, May 27, 2003

Filed:

Mar 1, 2001

Appl. No.:

09/797196

Inventors:

W. Robert Addington - Melbourne Beach FL
Robert E. Stephens - Kansas City MO
Stuart P. Miller - Melbourne Beach FL

Assignee:

Pneumoflex Systems L.L.C. - Melbourne FL

International Classification:

A61B 508

US Classification:

128897, 600529

Abstract:

The injection of an aerosol containing a chemostimulant into a patients throat to stimulate nociceptor (irritant) and c-fibre receptors is augmented by the inclusion of a medically safe and accepted contrast substance, such as barium. The addition of a contrast substance to the aerosol allows fluoroscopic observation of the patients (larynx) response, to facilitate a medical practitioners identification of whether the patient is at risk to one or more abnormal physiological conditions, such as oral or pharyngeal dysphagia, and pneumonia.

US Patent:

6655376, Dec 2, 2003

Filed:

Nov 18, 1999

Appl. No.:

09/442658

Inventors:

W. Robert Addington - Indialantic FL
Robert E. Stephens - Parkville MO

Assignee:

Pneumoflex Systems L.L.C. - Melbourne FL

International Classification:

A61M 1500

US Classification:

12820024, 12820014, 12820312

Abstract:

Whether a post surgery intubated patient is at risk for aspiration-based pneumonia is determined by requiring the patient to inhale an aerosol of tartaric acid that will stimulate a sensory innervation of the patients larynx, if functionally recovered, thereby causing the patient to cough. The resulting cough or lack of cough is graded to determine whether the patient is at risk for pneumonia caused by the aspiration of matter present in the patients mouth. In a further embodiment, the inability or difficulty of a patient to voluntarily expel potentially threatening fluid and matter from the patients airway can be remedied by repeated applications of the aerosol chemostimulant spray.

US Patent:

6679249, Jan 20, 2004

Filed:

Aug 30, 2001

Appl. No.:

09/943494

Inventors:

W. Robert Addington - Melbourne Beach FL
Robert E. Stephens - Kansas City MO
Stuart P. Miller - Melbourne Beach FL

Assignee:

Pneumoflex Systems, L.L.C. - Melbourne Beach FL

International Classification:

A61M 1100

US Classification:

12820014, 12820016, 12820312

Abstract:

An apparatus and method for treatment of a patient having a pulmonary disease involving chronic obstruction of the airways includes a container having therein a chamber containing a composition of L-tartrate in a pharmaceutically acceptable carrier; an opening connected to the chamber so as to provide an outlet therefor, the opening sized for producing droplets of a predetermined size range responsive to the composition being motivated from the chamber through the opening; and a source of motivating force connected with the chamber so as to motivate the composition through the opening to thereby cause nebulization of the composition. A treatment kit comprises the container described and a mouthpiece connectable to the container so as to be in fluid connection with the opening and downstream therefrom to thereby convey the nebulized composition into a patients mouth to thereby facilitate oral inhalation of the nebulized composition by the patient.

US Patent:

7343915, Mar 18, 2008

Filed:

Jul 16, 2002

Appl. No.:

10/483697

Inventors:

W. Robert Addington - Melbourne FL, US
Robert E. Stephens - Kansas City MO, US
Stuart P. Miller - Melbourne Beach FL, US

Assignee:

Pneumoflex Systems, L.L.C. - Melbourne FL

International Classification:

A61M 11/00

US Classification:

12820312, 12820023, 12820024

Abstract:

A apparatus and method for self-treatment of cardiac arrhythmia by a patient, comprising a container sized to be portable by the patient and having therein a chamber containing a medicament composition comprising a pharmaceutically acceptable carrier mixed with a chemoirritant, preferably L-tartaric acid; a nebulizing valve connected to the chamber so as to provide an outlet therefor; a source of motivating force connected with the chamber so as to motivate the composition through the opening in the nebulizing valve to thereby cause nebulization of the composition; a wireless transmitter responsive to activation of the nebulizer for sending a wireless signal requesting medical assistance; and a power source operatively connected for providing power; wherein the chemoirritant is mixed in the composition in an amount sufficient for causing the patient to produce an involuntary cough effective to maintain at least partial blood circulation.

US Patent:

8109266, Feb 7, 2012

Filed:

Mar 16, 2010

Appl. No.:

12/724785

Inventors:

W. Robert Addington - Melbourne Beach FL, US
Stuart P. Miller - Indialantic FL, US
Michael M. Phelipa - Melbourne FL, US
Robert E. Stephens - Parkville MO, US

Assignee:

Pneumoflex Systems, LLC - Melbourne FL

International Classification:

A61M 15/00

US Classification:

12820312

Abstract:

In accordance with non-limiting examples, a nebulizer includes a main body comprising an air channel section and further comprising a mixing chamber and a venturi positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.

US Patent:

8333190, Dec 18, 2012

Filed:

Jan 6, 2011

Appl. No.:

12/985685

Inventors:

W. Robert Addington - Melbourne Beach FL, US
Stuart P. Miller - Indialantic FL, US
Michael M. Phelipa - Melbourne FL, US
Robert E. Stephens - Parkville MO, US

Assignee:

Pneumoflex Systems, LLC - Melbourne FL

International Classification:

A61M 15/00

US Classification:

12820312

Abstract:

In accordance with non-limiting examples, a nebulizer includes a main body comprising an air channel section and further comprising a mixing chamber and a venturi positioned to be placed within the patient's oral cavity and configured to receive medicine and air and mix the medicine and air within the mixing chamber and receive the air flow through the venturi and cause the medicine entering the mixing chamber to be atomized by the action of air flowing through the venturi. An air flow sensor is associated with the main body and configured to measure the air flow created by the patient's one of at least inhaling and exhaling air.